logo
Breadcrumbs Image

Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market

Global Rare Disease Genetic Testing Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: Apr-2021 | Id: MACRC-59192 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Rare Disease Genetic Testing market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Quest Diagnostics
Ambry Genetics
3billion
Centogene
Strand Life Sciences
Invitae Corporation
Macrogen
Eurofins Scientific
Arup Laboratories
Perkin Elmer
Coopersurgical
LabCorp
Baylor Genetics
Fulgent Genetics
Progenity
Color Genomics
Opko Health
Myriad Genetics
Preventiongenetics

By Types:
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others

By Applications:
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
1.5 Market Analysis by Type
1.5.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Next-Generation Sequencing (NGS)
1.5.3 Array Technology
1.5.4 PCR-based Testing
1.5.5 Fluorescence in Situ Hybridization (FISH)
1.5.6 Sanger Sequencing
1.5.7 Karyotyping
1.5.8 Others
1.6 Market by Application
1.6.1 Global Rare Disease Genetic Testing Market Share by Application: 2022-2027
1.6.2 Research Laboratories and CROs
1.6.3 Diagnostic Laboratories
1.6.4 Hospitals and Clinics
1.6.5 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Rare Disease Genetic Testing Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Rare Disease Genetic Testing Market Players Profiles
3.1 Quest Diagnostics
3.1.1 Quest Diagnostics Company Profile
3.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Specification
3.1.3 Quest Diagnostics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Ambry Genetics
3.2.1 Ambry Genetics Company Profile
3.2.2 Ambry Genetics Rare Disease Genetic Testing Product Specification
3.2.3 Ambry Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 3billion
3.3.1 3billion Company Profile
3.3.2 3billion Rare Disease Genetic Testing Product Specification
3.3.3 3billion Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Centogene
3.4.1 Centogene Company Profile
3.4.2 Centogene Rare Disease Genetic Testing Product Specification
3.4.3 Centogene Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Strand Life Sciences
3.5.1 Strand Life Sciences Company Profile
3.5.2 Strand Life Sciences Rare Disease Genetic Testing Product Specification
3.5.3 Strand Life Sciences Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 Invitae Corporation
3.6.1 Invitae Corporation Company Profile
3.6.2 Invitae Corporation Rare Disease Genetic Testing Product Specification
3.6.3 Invitae Corporation Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Macrogen
3.7.1 Macrogen Company Profile
3.7.2 Macrogen Rare Disease Genetic Testing Product Specification
3.7.3 Macrogen Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Eurofins Scientific
3.8.1 Eurofins Scientific Company Profile
3.8.2 Eurofins Scientific Rare Disease Genetic Testing Product Specification
3.8.3 Eurofins Scientific Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Arup Laboratories
3.9.1 Arup Laboratories Company Profile
3.9.2 Arup Laboratories Rare Disease Genetic Testing Product Specification
3.9.3 Arup Laboratories Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Perkin Elmer
3.10.1 Perkin Elmer Company Profile
3.10.2 Perkin Elmer Rare Disease Genetic Testing Product Specification
3.10.3 Perkin Elmer Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Coopersurgical
3.11.1 Coopersurgical Company Profile
3.11.2 Coopersurgical Rare Disease Genetic Testing Product Specification
3.11.3 Coopersurgical Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 LabCorp
3.12.1 LabCorp Company Profile
3.12.2 LabCorp Rare Disease Genetic Testing Product Specification
3.12.3 LabCorp Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.13 Baylor Genetics
3.13.1 Baylor Genetics Company Profile
3.13.2 Baylor Genetics Rare Disease Genetic Testing Product Specification
3.13.3 Baylor Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.14 Fulgent Genetics
3.14.1 Fulgent Genetics Company Profile
3.14.2 Fulgent Genetics Rare Disease Genetic Testing Product Specification
3.14.3 Fulgent Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.15 Progenity
3.15.1 Progenity Company Profile
3.15.2 Progenity Rare Disease Genetic Testing Product Specification
3.15.3 Progenity Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.16 Color Genomics
3.16.1 Color Genomics Company Profile
3.16.2 Color Genomics Rare Disease Genetic Testing Product Specification
3.16.3 Color Genomics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.17 Opko Health
3.17.1 Opko Health Company Profile
3.17.2 Opko Health Rare Disease Genetic Testing Product Specification
3.17.3 Opko Health Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.18 Myriad Genetics
3.18.1 Myriad Genetics Company Profile
3.18.2 Myriad Genetics Rare Disease Genetic Testing Product Specification
3.18.3 Myriad Genetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.19 Preventiongenetics
3.19.1 Preventiongenetics Company Profile
3.19.2 Preventiongenetics Rare Disease Genetic Testing Product Specification
3.19.3 Preventiongenetics Rare Disease Genetic Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Rare Disease Genetic Testing Market Competition by Market Players
4.1 Global Rare Disease Genetic Testing Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Rare Disease Genetic Testing Revenue Market Share by Market Players (2016-2021)
4.3 Global Rare Disease Genetic Testing Average Price by Market Players (2016-2021)
5 Global Rare Disease Genetic Testing Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Rare Disease Genetic Testing Market Size (2016-2021)
5.1.2 Rare Disease Genetic Testing Key Players in North America (2016-2021)
5.1.3 North America Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.1.4 North America Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Rare Disease Genetic Testing Market Size (2016-2021)
5.2.2 Rare Disease Genetic Testing Key Players in East Asia (2016-2021)
5.2.3 East Asia Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.2.4 East Asia Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Rare Disease Genetic Testing Market Size (2016-2021)
5.3.2 Rare Disease Genetic Testing Key Players in Europe (2016-2021)
5.3.3 Europe Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.3.4 Europe Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Rare Disease Genetic Testing Market Size (2016-2021)
5.4.2 Rare Disease Genetic Testing Key Players in South Asia (2016-2021)
5.4.3 South Asia Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.4.4 South Asia Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Rare Disease Genetic Testing Market Size (2016-2021)
5.5.2 Rare Disease Genetic Testing Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.5.4 Southeast Asia Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Rare Disease Genetic Testing Market Size (2016-2021)
5.6.2 Rare Disease Genetic Testing Key Players in Middle East (2016-2021)
5.6.3 Middle East Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.6.4 Middle East Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Rare Disease Genetic Testing Market Size (2016-2021)
5.7.2 Rare Disease Genetic Testing Key Players in Africa (2016-2021)
5.7.3 Africa Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.7.4 Africa Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Rare Disease Genetic Testing Market Size (2016-2021)
5.8.2 Rare Disease Genetic Testing Key Players in Oceania (2016-2021)
5.8.3 Oceania Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.8.4 Oceania Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Rare Disease Genetic Testing Market Size (2016-2021)
5.9.2 Rare Disease Genetic Testing Key Players in South America (2016-2021)
5.9.3 South America Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.9.4 South America Rare Disease Genetic Testing Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Rare Disease Genetic Testing Market Size (2016-2021)
5.10.2 Rare Disease Genetic Testing Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Rare Disease Genetic Testing Market Size by Type (2016-2021)
5.10.4 Rest of the World Rare Disease Genetic Testing Market Size by Application (2016-2021)
6 Global Rare Disease Genetic Testing Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Rare Disease Genetic Testing Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Rare Disease Genetic Testing Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Rare Disease Genetic Testing Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Rare Disease Genetic Testing Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Rare Disease Genetic Testing Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Rare Disease Genetic Testing Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Rare Disease Genetic Testing Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Rare Disease Genetic Testing Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Rare Disease Genetic Testing Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Rare Disease Genetic Testing Consumption by Countries
7 Global Rare Disease Genetic Testing Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Rare Disease Genetic Testing (2022-2027)
7.2 Global Forecasted Revenue of Rare Disease Genetic Testing (2022-2027)
7.3 Global Forecasted Price of Rare Disease Genetic Testing (2022-2027)
7.4 Global Forecasted Production of Rare Disease Genetic Testing by Region (2022-2027)
7.4.1 North America Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.3 Europe Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.7 Africa Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.9 South America Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Rare Disease Genetic Testing Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Rare Disease Genetic Testing by Application (2022-2027)
8 Global Rare Disease Genetic Testing Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Rare Disease Genetic Testing by Country
8.2 East Asia Market Forecasted Consumption of Rare Disease Genetic Testing by Country
8.3 Europe Market Forecasted Consumption of Rare Disease Genetic Testing by Countriy
8.4 South Asia Forecasted Consumption of Rare Disease Genetic Testing by Country
8.5 Southeast Asia Forecasted Consumption of Rare Disease Genetic Testing by Country
8.6 Middle East Forecasted Consumption of Rare Disease Genetic Testing by Country
8.7 Africa Forecasted Consumption of Rare Disease Genetic Testing by Country
8.8 Oceania Forecasted Consumption of Rare Disease Genetic Testing by Country
8.9 South America Forecasted Consumption of Rare Disease Genetic Testing by Country
8.10 Rest of the world Forecasted Consumption of Rare Disease Genetic Testing by Country
9 Global Rare Disease Genetic Testing Sales by Type (2016-2027)
9.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2016-2021)
9.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2022-2027)
10 Global Rare Disease Genetic Testing Consumption by Application (2016-2027)
10.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2016-2021)
10.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2022-2027)
11 Global Rare Disease Genetic Testing Manufacturing Cost Analysis
11.1 Rare Disease Genetic Testing Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Rare Disease Genetic Testing
12 Global Rare Disease Genetic Testing Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Rare Disease Genetic Testing Distributors List
12.3 Rare Disease Genetic Testing Customers
12.4 Rare Disease Genetic Testing Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00